Abstract
Recently, we reported on indefinite islet graft survival in allotransplantation (rat to rat). This was achievable without the use of any immunosuppression by performing transplantation of culture-pretreated (22°C) islets of Langerhans under the renal capsule (r.c.) of chemically induced diabetic recipients. The aim of this study was to test this successful islet modulation technique in a xenogeneic animal model. Six groups of chemically induced diabetic, inbred, C57BL/6J mice received by transplantation either into the liver via the portal vein (i.po.) or under the renal capsule (r.c.) 300–350 either freshly or culture-pretreated (37°C and 22°C) Lewis rat islets without any immunosuppressive therapy. Histology was performed after rejection or post-transplant normoglycaemia (>120 days) for evaluation of the graft. Transplantation of freshly isolated islets resulted in 75% graft rejection 17 days after transplantation. Using culture pretreatment at 37°C, we noted 75% graft rejection 31 days after transplantation. In contrast, culture pretreatment at 22°C resulted in a marked prolongation of xenograft survival, 75% graft rejection occurring 58 days after transplantation, and in two cases there was indefinite graft survival (>120 days). Statistical analysis showed a significant prolongation of xenograft survival after culture pretreatment, with the most beneficial effect appearing after low-temperature culture at 22°C (P<0.05). Interestingly, xenograft survival was markedly prolonged only using the r.c. approach. Statistical comparison revealed a highly significant prolongation using the r.c. as transplantation site compared with i.po. (P<0.001). The prolongation was achievable by combining the r.c. as transplantation site and the culture pretreatment at low temperature (22°C). This effect is similar to the results in allotransplantation, but with a lower rate of indefinite graft survival.
Similar content being viewed by others
References
Lacy PE, Ricordi C, Finke EH, Effect of transplantation site and L3T4 treatment on survival of rat, hamster, and rabbit islet xenografts in mice. Transplantation 47:761–766, 1989
Auchincloss H, Xenogeneic transplantation. Transplantation 46:1–20, 1988
Tze WJ, Tai J, Cheung S, Human islet xenograft survival in diabetic rats. Transplantation 49:502–506, 1990
Lafferty KJ, Islet cell transplantation as a therapy for type I diabetes mellitus. Diabetes Nutr Metab 2:323–332, 1989
Lacy PE, Islet transplantation. Clin Chem 32/10 (B):B76-B82, 1986
Federlin K, Bretzel RG, Achievements in 20 years of islet transplantation research. Transplant Proc 18:1809–1813, 1986
Gray DWR, Morris PJ, Developments in isolated pancreatic islet transplantation. Transplantation 43:321–331, 1987
Woehrle M, Beyer K, Bretzel RG, Federlin K, Prevention of islet allograft rejection in experimental diabetes of the rat without immunosuppression of the host. Transplant Proc 21:2705–2706, 1989
Gotoh M, Ohzato H, Dono K, Kawai M, Yamamoto H, Kanai T, Monden M, Mori T, Successful islet isolation from preserved rat pancreas following pancreatic ductal collagenase at the time of harvesting. Horm Metab Res 25:1–4, 1990
Lacy PE, Davie JM, Finke EH, Prolongation of islet xenograft survival. Diabetes 30:285–291, 1981
Yasunami Y, Lacy PE, Davie JM, Finke EH, Prolongation of islet xenograft survival (rat to mouse) by in vitro culture at 37°C. Transplantation 35:381–384, 1983
Tze WJ, Tai J, Prolongation of islet allograft and xenograft in nonimmunosuppressed rat recipients. Metabolism 32:279–282, 1983
Kamei T, Yasunami Y, Terasaka R, Konomi K, Importance of transplant site for prolongation of islet xenograft survival (rat to mouse) after low temperature culture and cyclosporin A. Transplant Proc 21:2693–2694, 1989
Sullivan FP, Ricordi C, Hauptfeld V, Lacy PE, Effect of low temperature culture and site of transplantation on hamster islet xenograft survival (hamster to mouse). Transplantation 44:465–468, 1987
Wöhrle M, Beyer K, Bretzel RG, Federlin K, The influence of the culture temperature on insulin release, antigen expression and allograft survival of islets of Langerhans. Horm Metab Res 25:96–100, 1990
Wöhrle M, Markmann JF, Beyer K, Naji A, Bretzel RG, Federlin K, The influence of the implantation site (kidney capsule vs. portal vein) on islet survival. Horm Metab Res 25:163–165, 1990
Reece-Smith H, Du Troit DF, McShane P, Morris PJ, Prolonged survival of pancreatic islet allografts transplanted beneath the renal capsule. Diabetologia 23:343–346, 1981
Head J, Billingham R, Immunologically privileged sites in transplantation immunology and oncology. Perspect Biol Med 29:115–129, 1985
Opelz G, Terasaki PE. Lymphocyte antigenicity loss with retention of responsiveness. Science 184:464, 1974
Markmann JF, Tomaszewski J, Posselt AM, Levy MM, Woehrle M, Barker CF, Naji A, The effect of islet cell culture in vitro at 24°C on graft survival and MHC antigen expression. Transplantation 49:272–277, 1989
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jaeger, C., Wöhrle, M., Bretzel, R.G. et al. Effect of transplantation site and culture pretreatment on islet xenograft survival (rat to mouse) in experimental diabetes without immunosuppression of the host. Acta Diabetol 31, 193–197 (1994). https://doi.org/10.1007/BF00571950
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00571950